Question 1

What are the potential benefits and risks of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase III Study to Evaluate the Efficacy and Safety of AD-209 clinical trial (NCT06348576). Contact the study team or your healthcare provider for specific answers.

Question 2

How does AD-209 compare to my current treatment for hypertension?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase III Study to Evaluate the Efficacy and Safety of AD-209 clinical trial (NCT06348576). Contact the study team or your healthcare provider for specific answers.

Question 3

What should I expect during the eight weeks of the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase III Study to Evaluate the Efficacy and Safety of AD-209 clinical trial (NCT06348576). Contact the study team or your healthcare provider for specific answers.

Question 4

Will I have to stop taking any current medications if I join this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase III Study to Evaluate the Efficacy and Safety of AD-209 clinical trial (NCT06348576). Contact the study team or your healthcare provider for specific answers.

Question 5

What kind of monitoring will be done during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase III Study to Evaluate the Efficacy and Safety of AD-209 clinical trial (NCT06348576). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my health be assessed throughout the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase III Study to Evaluate the Efficacy and Safety of AD-209 clinical trial (NCT06348576). Contact the study team or your healthcare provider for specific answers.

What this study is about